{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:11:49Z","timestamp":1791616309995,"version":"4.3.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":371,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2021R1C1C1005725"],"award-info":[{"award-number":["2021R1C1C1005725"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006436","name":"Celgene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AWD0009884-GR120668"],"award-info":[{"award-number":["AWD0009884-GR120668"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["MS152"],"award-info":[{"award-number":["MS152"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1S10OD028504"],"award-info":[{"award-number":["1S10OD028504"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1S10OD025132"],"award-info":[{"award-number":["1S10OD025132"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002889","name":"Foundation for Prader-Willi Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002889","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.ymthe.2024.05.034","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T19:31:59Z","timestamp":1716579119000},"page":"2662-2675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Newly developed oral bioavailable EHMT2 inhibitor as a potential epigenetic therapy for Prader-Willi syndrome"],"prefix":"10.1016","volume":"32","author":[{"given":"Sung Eun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-Ae","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang-Su","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meaghan","family":"Donahue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Velez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6188-8806","authenticated-orcid":false,"given":"Yong-hui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2024.05.034_bib1","series-title":"GeneReviews((R))","article-title":"Prader-Willi Syndrome","author":"Driscoll","year":"1993"},{"key":"10.1016\/j.ymthe.2024.05.034_bib2","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/ajmg.a.38582","article-title":"Prader-Willi syndrome and early-onset morbid obesity NIH rare disease consortium: A review of natural history study","volume":"176","author":"Butler","year":"2018","journal-title":"Am. J. Med. Genet. A."},{"key":"10.1016\/j.ymthe.2024.05.034_bib3","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3390\/genes10090713","article-title":"The Global Prader-Willi Syndrome Registry: Development, Launch, and Early Demographics","volume":"10","author":"Bohonowych","year":"2019","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.ymthe.2024.05.034_bib4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.trsl.2019.02.012","article-title":"Epigenetic therapy of Prader-Willi syndrome","volume":"208","author":"Kim","year":"2019","journal-title":"Transl. Res."},{"key":"10.1016\/j.ymthe.2024.05.034_bib5","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/ng.158","article-title":"Prader-Willi phenotype caused by paternal deficiency for the HBII-85 C\/D box small nucleolar RNA cluster","volume":"40","author":"Sahoo","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2024.05.034_bib6","doi-asserted-by":"crossref","first-page":"18614","DOI":"10.1038\/srep18614","article-title":"Snord116 is critical in the regulation of food intake and body weight","volume":"6","author":"Qi","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2024.05.034_bib7","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.1371\/journal.pgen.0030235","article-title":"Deletion of the MBII-85 snoRNA gene cluster in mice results in postnatal growth retardation","volume":"3","author":"Skryabin","year":"2007","journal-title":"PLoS Genet."},{"key":"10.1016\/j.ymthe.2024.05.034_bib8","doi-asserted-by":"crossref","first-page":"e1709","DOI":"10.1371\/journal.pone.0001709","article-title":"SnoRNA Snord116 (Pwcr1\/MBII-85) deletion causes growth deficiency and hyperphagia in mice","volume":"3","author":"Ding","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2024.05.034_bib9","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.3390\/ijms22073613","article-title":"A Comprehensive Review of Genetically Engineered Mouse Models for Prader-Willi Syndrome Research","volume":"22","author":"Kummerfeld","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2024.05.034_bib10","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1172\/JCI97007","article-title":"Hypothalamic loss of Snord116 recapitulates the hyperphagia of Prader-Willi syndrome","volume":"128","author":"Polex-Wolf","year":"2018","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2024.05.034_bib11","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/ajmg.c.30273","article-title":"Prader-Willi syndrome and Angelman syndrome","volume":"154C","author":"Buiting","year":"2010","journal-title":"Am. J. Med. Genet. C Semin. Med. Genet."},{"key":"10.1016\/j.ymthe.2024.05.034_bib12","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/ng0994-52","article-title":"Deletions of a differentially methylated CpG island at the SNRPN gene define a putative imprinting control region","volume":"8","author":"Sutcliffe","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2024.05.034_bib13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nm.4257","article-title":"Targeting the histone methyltransferase G9a activates imprinted genes and improves survival of a mouse model of Prader-Willi syndrome","volume":"23","author":"Kim","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2024.05.034_bib14","doi-asserted-by":"crossref","first-page":"14996","DOI":"10.1074\/jbc.M211753200","article-title":"Role of histone methyltransferase G9a in CpG methylation of the Prader-Willi syndrome imprinting center","volume":"278","author":"Xin","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2024.05.034_bib15","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/ng.297","article-title":"Large histone H3 lysine 9 dimethylated chromatin blocks distinguish differentiated from embryonic stem cells","volume":"41","author":"Wen","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2024.05.034_bib16","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.tips.2019.07.002","article-title":"Potential of Epigenetic Therapy for Prader-Willi Syndrome","volume":"40","author":"Wang","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ymthe.2024.05.034_bib17","doi-asserted-by":"crossref","first-page":"8931","DOI":"10.1021\/jm401480r","article-title":"Discovery of an in\u00a0vivo chemical probe of the lysine methyltransferases G9a and GLP","volume":"56","author":"Liu","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ymthe.2024.05.034_bib18","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1158\/1541-7786.MCR-08-0497","article-title":"Distinct Roles for Histone Methyltransferases G9a and GLP in Cancer Germ-Line Antigen Gene Regulation in Human Cancer Cells and Murine Embryonic Stem Cells","volume":"7","author":"Link","year":"2009","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.ymthe.2024.05.034_bib19","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1101\/gad.989402","article-title":"G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis","volume":"16","author":"Tachibana","year":"2002","journal-title":"Gene Dev."},{"key":"10.1016\/j.ymthe.2024.05.034_bib20","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1158\/2159-8290.CD-19-0532","article-title":"Gain-of-Function Genetic Alterations of G9a Drive Oncogenesis","volume":"10","author":"Kato","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ymthe.2024.05.034_bib21","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ccell.2018.09.001","article-title":"MYC Interacts with the G9a Histone Methyltransferase to Drive Transcriptional Repression and Tumorigenesis","volume":"34","author":"Tu","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ymthe.2024.05.034_bib22","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/s41591-019-0499-y","article-title":"Inhibition of a G9a\/DNMT network triggers immune-mediated bladder cancer regression","volume":"25","author":"Segovia","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2024.05.034_bib23","doi-asserted-by":"crossref","first-page":"11591","DOI":"10.18632\/aging.102558","article-title":"Pharmacological inhibition of G9a\/GLP restores cognition and reduces oxidative stress, neuroinflammation and beta-Amyloid plaques in an early-onset Alzheimer's disease mouse model","volume":"11","author":"Grinan-Ferre","year":"2019","journal-title":"Aging"},{"key":"10.1016\/j.ymthe.2024.05.034_bib24","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/brain\/awy354","article-title":"Inhibition of EHMT1\/2 rescues synaptic and cognitive functions for Alzheimer's disease","volume":"142","author":"Zheng","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.ymthe.2024.05.034_bib25","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1182\/blood-2015-02-629972","article-title":"Inhibition of G9a methyltransferase stimulates fetal hemoglobin production by facilitating LCR\/\u03b3-globin looping","volume":"126","author":"Krivega","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.05.034_bib26","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nchembio.599","article-title":"A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells","volume":"7","author":"Vedadi","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ymthe.2024.05.034_bib27","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1021\/acs.jmedchem.6b01645","article-title":"Discovery of Potent and Selective Inhibitors for G9a-Like Protein (GLP) Lysine Methyltransferase","volume":"60","author":"Xiong","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ymthe.2024.05.034_bib28","doi-asserted-by":"crossref","first-page":"10506","DOI":"10.1021\/acs.jmedchem.2c00652","article-title":"Discovery of the first-in-class G9a\/GLP covalent inhibitors","volume":"65","author":"Park","year":"2022","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ymthe.2024.05.034_bib29","series-title":"Amine-substitued Aryl or Heteroaryl Compounds as EHMT1 and EHMT2 Inhibitors","author":"Campbell","year":"2017"},{"key":"10.1016\/j.ymthe.2024.05.034_bib30","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1039\/C4MD00274A","article-title":"Identification of 2,4-diamino-6,7-dimethoxyquinoline derivatives as G9a inhibitors\u2020Electronic supplementary information (ESI) available. See DOI: 10.1039\/c4md00274a","volume":"5","author":"Srimongkolpithak","year":"2014","journal-title":"Medchemcomm"},{"key":"10.1016\/j.ymthe.2024.05.034_bib31","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1016\/j.bmc.2017.06.021","article-title":"Structure-activity relationship studies of G9a-like protein (GLP) inhibitors","volume":"25","author":"Xiong","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ymthe.2024.05.034_bib32","article-title":"Novel brain-penetrant inhibitor of G9a methylase blocks Alzheimer\u2019s disease proteopathology for precision medication","author":"Xie","year":"2023","journal-title":"medRxiv"},{"key":"10.1016\/j.ymthe.2024.05.034_bib33","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1093\/hmg\/8.8.1357","article-title":"Paternal deletion from Snrpn to Ube3a in the mouse causes hypotonia, growth retardation and partial lethality and provides evidence for a gene contributing to Prader-Willi syndrome","volume":"8","author":"Tsai","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2024.05.034_bib34","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1093\/nar\/gkh670","article-title":"Regulation of the large (approximately 1000 kb) imprinted murine Ube3a antisense transcript by alternative exons upstream of Snurf\/Snrpn","volume":"32","author":"Landers","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2024.05.034_bib35","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13148-022-01419-z","article-title":"Drugging the epigenome in the age of precision medicine","volume":"15","author":"Feehley","year":"2023","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.ymthe.2024.05.034_bib36","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1038\/s41380-023-02208-7","article-title":"Novel epigenetic molecular therapies for imprinting disorders","volume":"28","author":"Wang","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ymthe.2024.05.034_bib37","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ab.2005.04.007","article-title":"A coupled fluorescent assay for histone methyltransferases","volume":"342","author":"Collazo","year":"2005","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ymthe.2024.05.034_bib38","first-page":"e65761","article-title":"Intrathecal Injection of Newborn Mouse for Genome Editing and Drug Delivery","volume":"8","author":"Lu","year":"2024","journal-title":"JoVE"},{"key":"10.1016\/j.ymthe.2024.05.034_bib39","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.celrep.2017.03.050","article-title":"TRPV1 Regulates Stress Responses through HDAC2","volume":"19","author":"Wang","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2024.05.034_bib40","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ymthe.2024.05.034_bib41","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.ymthe.2024.05.034_bib42","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624003368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624003368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T03:47:02Z","timestamp":1778816822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001624003368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1525001624003368"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.05.034","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Newly developed oral bioavailable EHMT2 inhibitor as a potential epigenetic therapy for Prader-Willi syndrome","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.05.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024","name":"copyright","label":"Copyright"}]}}